- Public offer variants
- $76 first-month quarterly presentation; $89/month in another product version
- Supply label
- Quarterly 1,000 mg presentation; verify actual prescription
- Renewal
- Automatic refill language; obtain the exact billing schedule
The advertised preparation and care pathway
System Labs lists a NAD+ injection treatment within an online clinician-review service. The page describes pharmacy fulfillment, support and automatic refills. A quarterly-supply presentation identifies 1,000 mg, but the final concentration, container quantity and prescribed supply still need confirmation for the actual order rather than being reconstructed from a headline.
The brand also sells a nasal preparation, reviewed separately. Neither its bottle price nor its first-month promotion should be used to fill gaps in the injectable offer. We have not completed the intake, received a prescription or tested the shipped product. This article assesses the public purchasing information and the questions needed to make it comparable.
Why the catalog asks for a quote
During the source check, a rendered injection offer paired a quarterly-supply label with $76 for the first month and a $126 reference figure. Another fetched product presentation displayed $89 per month. The difference could reflect a selected term or another offer variation; the public material reviewed did not establish one unambiguous invoice schedule across those presentations.
We therefore keep the catalog entry quote-only instead of choosing the smallest number or inventing a renewal rate. Ask for the selected supply period, initial charge, renewal amount and timing in writing. A first-month equivalent attached to a longer supply should not be mistaken for the full payment due when the order is placed.
Fulfillment terms affect cancellation
The provider's terms allow an order to be canceled before the prescription is sent to the partner pharmacy for fulfillment, with any eligible temporary card authorization removed. Once medication has been processed and shipped, ordinary returns are not offered. Readers should identify that fulfillment point before assuming that pausing a subscription reverses an existing pharmacy order.
The terms also describe reporting damaged or incorrect medication within seven days, with a replacement decision handled by the company. Confirm the process for a shipment that arrives outside its required conditions. Shipping speed and cold packaging, where advertised, do not establish indefinite stability or replace the actual pharmacy storage and beyond-use instructions.
Keep the price question separate from effectiveness
System Labs promotes the injection around energy, focus, recovery and aging-related cellular processes. A mechanism involving NAD+ is not proof of a predictable result from the dispensed preparation. We did not independently establish the advertised outcomes or inspect a finished-product trial that resolves the benefits for a particular reader's intended purpose.
Ask the clinician what is being assessed and why this route is proposed, then request the pharmacy identity, full formulation and relevant quality documentation. Compounded preparations are not FDA-approved, even when a pharmacy is described as registered or licensed. The practical finding is a documented injection offering with unresolved commercial variants; its value cannot be assessed reliably until the specific prescription and complete billing terms are supplied.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.